Rituximab treatment in pediatric-onset multiple sclerosis.
Markus BreuFredrik SandesjöRuxandra-Iulia MilosJan SvobodaJonatan SalzerLisa SchneiderJulian Benedikt ReicheltAnnikki BertoliniAstrid BlaschekKatharina FinkRomana HöftbergerJan LyckeKevin RostásyRainer SeidlSandy SiegertRonny WickströmBarbara KornekPublished in: European journal of neurology (2024)
Our study provides class IV evidence that RTX reduces clinical and radiological activity in pediatric-onset multiple sclerosis.